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Background/Introduction
Management of preoperative antiplatelet therapy in coron-
ary surgery is still variable among surgeons. Guidelines
collide with prejudices: replacement of aspirin with low
molecular weight heparin (LMWH) is still performed in
many Centers due to a presumed minor risk of intraopera-
tive bleeding, even though supporting evidences are weak
and detrimental effects are well-described.
Aims/Objectives
The purpose of this study is to analyse postoperative
bleedings in patients scheduled for elective primary iso-
lated on-pump coronary artery bypass grafting (CABG),
depending on preoperative continuation of aspirin or its
replacement with LMWH, since direct and unbiased
comparisons are lacking.
Method
Retrospectively, 200 patients were included in Group 1,
in which aspirin was stopped at least five days before sur-
gery and replaced with enoxaparin, and 200 patients in
Group 2, in which aspirin was continued until surgery.
Postoperative bleedings and surgical complications were
monitored during hospitalization.
Results
Postoperative bleeding was lower in Group 2 compared
to Group 1 in the first hour after operation (p = 0.005),
in the following 12 hours from surgery (p < 0.001), and
considering the overall blood loss with reduced major
postoperative bleeding events rate (p < 0.001). There
were not differences in the use of blood products and
reoperation for bleeding. Patients in Group 2 tended to
have lower values of postoperative C-reactive protein
(p = 0.068). Aspirin withdrawal before surgery was an
independent predictor of major postoperative bleeding
at Logistic regression, while statin treatment might exert
a protective effect (p = 0.085). Combined aspirin and
statin treatment is even more beneficial (p = 0.031).
After propensity score adjustment, aspirin protective
effect carries an adjusted odds ratio of 0.317 (p = 0.001).
Discussion/Conclusion
Postoperative bleeding was reduced in patients who con-
tinued aspirin until the day of surgery compared to
patients who replaced it with LMWH. This finding may
be due to a reduction in postoperative inflammatory
reaction, since statin treatment played a protective role
and C-reactive protein levels tended to be reduced in
patients who continued aspirin.
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